Thank you - that’s a great example of why I asked the question.
in saying that though, if Acadia decide to develop Trof for that indication and if successful NEU still receive royalties for it, so an interesting position,
Timing must be a consideration though - I hope Acadia can’t lock out indications and just go slow, preventing access for NNZ2591.
This will only be an issue if another company is licensed for 2581
- Forums
- ASX - By Stock
- NEU
- Ann: Investor Presentation, 14 March 2023
Ann: Investor Presentation, 14 March 2023, page-45
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.45 |
Change
-0.070(0.34%) |
Mkt cap ! $2.613B |
Open | High | Low | Value | Volume |
$20.60 | $20.77 | $20.32 | $3.866M | 188.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 237 | $20.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.49 | 1026 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2633 | 20.380 |
3 | 1467 | 20.360 |
1 | 1033 | 20.350 |
2 | 1853 | 20.340 |
1 | 828 | 20.320 |
Price($) | Vol. | No. |
---|---|---|
20.490 | 1026 | 2 |
20.550 | 2289 | 3 |
20.560 | 639 | 2 |
20.570 | 631 | 3 |
20.590 | 828 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online